Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Korro Bio, Inc. before investing.

In this article, we go over a few key elements for understanding Korro Bio, Inc.’s stock price such as:

• Korro Bio, Inc.’s current stock price and volume
• Why Korro Bio, Inc.’s stock price changed recently
• Upgrades and downgrades for KRRO from analysts
• KRRO’s stock price momentum as measured by its relative strength

About Korro Bio, Inc. (KRRO)

Before we jump into Korro Bio, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company’s lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson’s disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Want to learn more about Korro Bio, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Korro Bio, Inc..

Korro Bio, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Korro Bio, Inc.’s stock price was $10.370.

Korro Bio, Inc. is down 0.77% from its previous closing price of $10.450.

During the last market session, Korro Bio, Inc.’s stock traded between $9.760 and $10.530. Currently, there are approximately 11.60 million shares outstanding for Korro Bio, Inc..

Korro Bio, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Korro Bio, Inc. Stock Price History

Korro Bio, Inc.’s (KRRO) price is currently down 21.32% so far this month.

During the month of July, Korro Bio, Inc.’s stock price has reached a high of $15.550 and a low of $9.760.

Over the last year, Korro Bio, Inc. has hit prices as high as $55.890 and as low as $5.204. Year to date, Korro Bio, Inc.’s stock is up 29.46%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Korro Bio, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Korro Bio, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Korro Bio, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Korro Bio, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Korro Bio, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Korro Bio, Inc. (KRRO) by visiting AAII Stock Evaluator.

Relative Price Strength of Korro Bio, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Korro Bio, Inc. has a weighted four-quarter relative price strength of 3.53%, which translates to a Momentum Score of 65 and is considered to be Strong.

Want to learn more about how Korro Bio, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Korro Bio, Inc. Stock Price: Bottom Line

As of July 31, 2026, Korro Bio, Inc.’s stock price is $10.370, which is down 0.77% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Korro Bio, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.